Operating Lease, Right-of-Use Asset of Bioventus Inc. from 31 Dec 2020 to 27 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Bioventus Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 27 Sep 2025.
  • Bioventus Inc. Operating Lease, Right-of-Use Asset for the quarter ending 27 Sep 2025 was $5,830,000, a 40% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Bioventus Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,830,000 -$3,949,000 -40% 27 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $6,225,000 -$4,141,000 -40% 28 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $6,631,000 -$5,831,000 -47% 29 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $6,506,000 -$6,847,000 -51% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $9,779,000 -$4,519,000 -32% 28 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $10,366,000 -$4,872,000 -32% 29 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $12,462,000 -$3,601,000 -22% 30 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $13,353,000 -$3,337,000 -20% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $14,298,000 -$2,006,000 -12% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $15,238,000 -$3,104,000 -17% 01 Jul 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $16,063,000 -$2,675,000 -14% 01 Apr 2023 10-Q 16 May 2023 2023 Q1
Q4 2022 $16,690,000 -$496,000 -2.9% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $16,304,000 -$634,000 -3.7% 01 Oct 2022 10-Q 21 Nov 2022 2022 Q3
Q2 2022 $18,342,000 +$673,000 +3.8% 02 Jul 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $18,738,000 +$678,000 +3.8% 02 Apr 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $17,186,000 +$2,225,000 +15% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $16,938,000 02 Oct 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $17,669,000 03 Jul 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $18,060,000 03 Apr 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $14,961,000 31 Dec 2020 10-K 11 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.